Disclosure Documents under Rule 12g3-2(b) of the Securities Exchange Act of 1934

We publish the following documents in English to receive exemption from having to register a class of equity securities under Section 12(g) of the Securities Exchange Act of 1934.

Disclosure Documents

FY2024
November 26, 2024

Notice of Receipt of Dividend from JT's Consolidated SubsidiaryPDFを開くPDF:181kb

Extraordinary ReportPDFを開くPDF:78kb

Amendment to Shelf Registration StatementPDFを開くPDF:78kb

November 21, 2024

JT Announces New Executive AppointmentsPDFを開くPDF:37kb

October 31, 2024

Consolidated Financial Results the Nine Months Ended September 30,2024 <under IFRS>PDFを開くPDF:88kb

2024 Third Quarter Results (CFO Presentation)PDFを開くPDF:993kb

October 7, 2024

JT Group Completes Acquisition of Vector Group Ltd.PDFを開くPDF:260kb

September 18, 2024

Notice of withdrawal and refiling of Premerger Notification and Report Form under the HSR Act and extension of tender offer to acquire Vector Group Ltd.PDFを開くPDF:182kb

September 5, 2024

Notice of Change in Specified SubsidiaryPDFを開くPDF:338kb

August 26, 2024

Notice of Receipt of Dividend from JT’s Consolidated SubsidiaryPDFを開くPDF:185kb

Extraordinary ReportPDFを開くPDF:82kb

Amendment to Shelf Registration StatementPDFを開くPDF:84kb

August 22, 2024

Extraordinary ReportPDFを開くPDF:163kb

Amendment to Shelf Registration StatementPDFを開くPDF:77kb

August 21, 2024

JT Group to Acquire Vector Group Ltd.PDFを開くPDF:255kb

August 6, 2024

Shelf Registration StatementPDFを開くPDF:176kb

Overview of Business and Trends in Principal Management BenchmarksPDFを開くPDF:229kb

Statement verifying eligibility for use of “Reference Method”PDFを開くPDF:174kb

August 2, 2024

Consolidated Financial Results the Six Months Ended June 30,2024 <under IFRS>PDFを開くPDF:313kb

2024 Second Quarter Results (CFO Presentation)PDFを開くPDF:408kb

JT Announces New Executive AppointmentPDFを開くPDF:157kb

Semi-annual Securities ReportPDFを開くPDF:278kb

Written ConfirmationPDFを開くPDF:34kb

May 9, 2024

Consolidated Financial Results the Three Months Ended March 31, 2024 <under IFRS>PDFを開くPDF:318kb

2024 First Quarter Result (CFO Presentation)PDFを開くPDF:372kb

JT Announces New Executive AppointmentPDFを開くPDF:155kb

Quarterly Securities ReportPDFを開くPDF:227kb

Written ConfirmationPDFを開くPDF:33kb

April 19, 2024

Notice Regarding Completion of Payment for Disposal of Treasury Shares Towards Restricted Stock Remuneration and Performance Share UnitsPDFを開くPDF:154kb

April 5, 2024

Notice concerning Issuance of Euro Denominated Senior Unsecured Notes by a SubsidiaryPDFを開くPDF:320kb

March 27, 2024

Notice of Receipt of Dividend from JT’s Consolidated SubsidiaryPDFを開くPDF:174kb

Extraordinary ReportPDFを開くPDF:77kb

Amendment to Shelf Registration StatementPDFを開くPDF:77kb

Amended Statement of Securities Registration StatementPDFを開くPDF:149kb

March 25, 2024

Extraordinary ReportPDFを開くPDF:212kb

Amendment to Shelf Registration StatementPDFを開くPDF:156kb

Amended Statement of Securities Registration StatementPDFを開くPDF:151kb

March 22, 2024

Notice Concerning Disposal of Treasury Shares Towards Restricted Stock Remuneration and Performance Share UnitsPDFを開くPDF:237kb

Securities Registration StatementPDFを開くPDF:327kb

Annual Securities ReportPDFを開くPDF:1624kb

Written ConfirmationPDFを開くPDF:33kb

Management's Report on Internal Control over Financial ReportingPDFを開くPDF:38kb

February 27, 2024

Notice of ConvocationPDFを開くPDF:3.7mb

Matters NOT Included in Delivered Documents Concerning Notice of ConvocationPDFを開くPDF:352kb

February 13, 2024

Consolidated Financial Results for the Fiscal Year Ended December 31, 2023 <under IFRS>PDFを開くPDF:590kb

2023 Full Year Results & 2024 Forecast (All Presentation)PDFを開くPDF:1.04mb

Notice of Reduction in Amount of Legal Capital SurplusPDFを開くPDF:303kb

Notice Concerning Payment of Dividends from SurplusPDFを開くPDF:245kb

January 5, 2024

Extraordinary ReportPDFを開くPDF:82kb

Amendment to Shelf Registration StatementPDFを開くPDF:84kb
FY2023
December 20, 2023

Notice of Return of Dividend to JT’s Consolidated SubsidiaryPDFを開くPDF:229kb

Extraordinary ReportPDFを開くPDF:180kb

Amendment to Shelf Registration StatementPDFを開くPDF:154kb

November 17, 2023

JT Announces New Executive AppointmentsPDFを開くPDF:151kb

October 31, 2023

Consolidated Financial Results for the Nine Months Ended September 30, 2023 <under IFRS>PDFを開くPDF:318kb

2023 Third Quarter Results (CFO Presentation)PDFを開くPDF:720kb

Quarterly Securities ReportPDFを開くPDF:269kb

Written ConfirmationPDFを開くPDF:32kb

August 29, 2023

Notice of Receipt of Dividend from JT’s Consolidated SubsidiaryPDFを開くPDF:229kb

Extraordinary ReportPDFを開くPDF:179kb

Amendment to Shelf Registration StatementPDFを開くPDF:154kb

August 23, 2023

Notice of Change in Specified SubsidiaryPDFを開くPDF:530kb

Extraordinary ReportPDFを開くPDF:240kb

Amendment to Shelf Registration StatementPDFを開くPDF:156kb

July 31, 2023

Consolidated Financial Results for the Six Months Ended June 30, 2023 <under IFRS>PDFを開くPDF:406kb

2023 Second Quarter Results (CFO Presentation)PDFを開くPDF:752kb

JT Announces New Executive AppointmentsPDFを開くPDF:143kb

Quarterly Securities ReportPDFを開くPDF:274kb

Written ConfirmationPDFを開くPDF:32kb

July 12, 2023

Notice Regarding Completion of Payment for Disposal of Treasury Shares Towards Restricted Stock Remuneration and Performance Share UnitsPDFを開くPDF:58kb

June 19, 2023

Notice Concerning Disposal of Treasury Shares Towards Restricted Stock Remuneration and Performance Share UnitsPDFを開くPDF:61kb

Securities Registration StatementPDFを開くPDF:71kb

May 8, 2023

Documents presented at the Tobacco Investor ConferencePDFを開くPDF:141kb

May 2, 2023

Consolidated Financial Results for the Three Months Ended March 31, 2023 <under IFRS>PDFを開くPDF:338kb

2023 First Quarter Results (CFO Presentation)PDFを開くPDF:554kb

JT Announces New Executive AppointmentsPDFを開くPDF:92kb

Quarterly Securities ReportPDFを開くPDF:235kb

Written ConfirmationPDFを開くPDF:32kb

April 14, 2023

Notice concerning Issuance of 15th, 16th and 17th Series Straight BondsPDFを開くPDF:147kb

Shelf Registration SupplementPDFを開くPDF:382kb

Overview of Business and Trends in Principal Management BenchmarksPDFを開くPDF:159kb

Minutes of the Ordinary Meeting of the Board of Directors (Certified Extract)PDFを開くPDF:105kb

March 30, 2023

Notice of Receipt of Dividend from JT’s Consolidated SubsidiaryPDFを開くPDF:121kb

Extraordinary ReportPDFを開くPDF:116kb

Amendment to Shelf Registration StatementPDFを開くPDF:128kb

March 27, 2023

Extraordinary ReportPDFを開くPDF:221kb

Amendment to Shelf Registration StatementPDFを開くPDF:155kb

March 24, 2023

Annual Securities ReportPDFを開くPDF:1.63mb

Written ConfirmationPDFを開くPDF:196kb

Management's Report on Internal Control over Financial ReportingPDFを開くPDF:209kb

March 1, 2023

ARTICLES OF INCORPORATIONPDFを開くPDF:174kb

February 28, 2023

Notice of ConvocationPDFを開くPDF:3.2mb

Matters NOT Included in Delivered Documents Concerning Notice of ConvocationPDFを開くPDF:297kb

Supplementary Explanation for “Item 3: Election of Five (5) Audit & Supervisory Board Members” of the 38th Ordinary General Meeting of ShareholdersPDFを開くPDF:146kb

February 14, 2023

Consolidated Financial Results for the Fiscal Year Ended December 31, 2022 <under IFRS>PDFを開くPDF:482kb

Business Plan 2023 (Presentation)PDFを開くPDF:909kb

2022 Results & 2023 Forecast (Presentation)PDFを開くPDF:290kb

Tobacco Business 2022 Results & 2023 Outlook (Presentation)PDFを開くPDF:226kb

Opinion of the Board of Directors on the Shareholder’s ProposalPDFを開くPDF:198kb

January 5, 2023

Extraordinary ReportPDFを開くPDF:33kb

Amendment to Shelf Registration StatementPDFを開くPDF:34kb
FY2022
November 25, 2022

JT Announces New Executive AppointmentsPDFを開くPDF:285kb

October 31, 2022

Consolidated Financial Results for the Nine Months Ended September 30, 2022 <under IFRS>PDFを開くPDF:327kb

2022 Third Quarter Results (CFO Presentation)PDFを開くPDF:859kb

Notice concerning revised dividends guidancePDFを開くPDF:68kb

Quarterly Securities ReportPDFを開くPDF:910kb

Written ConfirmationPDFを開くPDF:17kb

October 20, 2022

Notice concerning Issuance of U.S. Dollar Denominated Senior Unsecured Notes by a SubsidiaryPDFを開くPDF:149kb

September 15, 2022

Notice Regarding Conclusion of Saint-Germain Share Transfer AgreementPDFを開くPDF:138kb

August 31, 2022

Change Report No. 9PDFを開くPDF:20kb

August 26, 2022

Notice of Receipt of Dividend from JT’s Consolidated SubsidiaryPDFを開くPDF:120kb

Extraordinary ReportPDFを開くPDF:179kb

Amendment to Shelf Registration StatementPDFを開くPDF:154kb

August 8, 2022

Amendment Report of Quarterly Securities ReportPDFを開くPDF:237kb

Written ConfirmationPDFを開くPDF:200kb

Amendment to Shelf Registration StatementPDFを開くPDF:204kb

August 5, 2022

Shelf Registration StatementPDFを開くPDF:96kb

Overview of Business and Trends in Principal Management BenchmarksPDFを開くPDF:244kb

Statement verifying eligibility for use of “Reference Method”PDFを開くPDF:52kb

July 29, 2022

Consolidated Financial Results for the Six Months Ended June 30, 2022 <under IFRS>PDFを開くPDF:421kb

2022 Second Quarter Results (CFO Presentation)PDFを開くPDF:569kb

Quarterly Securities ReportPDFを開くPDF:896kb

Written ConfirmationPDFを開くPDF:200kb

May 24, 2022

Notice Regarding Completion of Payment for Allocation of Treasury Stock towards Restricted Stock Remuneration PlanPDFを開くPDF:239kb

April 28, 2022

Consolidated Financial Results for the Three Months Ended March 31, 2022 <under IFRS>PDFを開くPDF:386kb

2022 First Quarter Results (CFO Presentation)PDFを開くPDF:926kb

Allocation of Treasury Stock towards Restricted Stock Remuneration PlanPDFを開くPDF:192kb

Securities Registration StatementPDFを開くPDF:181kb

Quarterly Securities ReportPDFを開くPDF:468kb

Written ConfirmationPDFを開くPDF:199kb

March 28, 2022

Notice of Receipt of Dividend from JT’s Consolidated SubsidiaryPDFを開くPDF:120kb

Extraordinary ReportPDFを開くPDF:115kb

Amendment to Shelf Registration StatementPDFを開くPDF:127kb

March 24, 2022

Extraordinary ReportPDFを開くPDF:137kb

Amendment to Shelf Registration StatementPDFを開くPDF:128kb

March 23, 2022

Annual Securities ReportPDFを開くPDF:1267kb

Written ConfirmationPDFを開くPDF:197kb

Management's Report on Internal Control over Financial ReportingPDFを開くPDF:208kb

ARTICLES OF INCORPORATIONPDFを開くPDF:187kb

NOTICE OF RESOLUTIONS AT THE 37TH ORDINARY GENERAL MEETING OF SHAREHOLDERSPDFを開くPDF:121kb

March 11, 2022

Notice of Change in Specified SubsidiaryPDFを開くPDF:172kb

February 25, 2022

Notice of ConvocationPDFを開くPDF:2.27mb

Materials Disclosed via The Internet Concerning Notice of ConvocationPDFを開くPDF:340kb

Supplementary Explanation Regarding Proposition “Item 3: Partial Amendment to the Articles of Incorporation (ii)” to Be Submitted at the 37th Ordinary General Meeting of ShareholdersPDFを開くPDF:105kb

February 14, 2022

Consolidated Financial Results for the Fiscal Year Ended December 31, 2021 <under IFRS>PDFを開くPDF:406kb

Business Plan 2022 (Presentation)PDFを開くPDF:1191kb

2021 Results & 2022 Forecast (Presentation)PDFを開くPDF:294kb

2021 International Tobacco Business Results & 2022 Tobacco Business Outlook (Presentation)PDFを開くPDF:295kb

Notice Concerning the Abolition of the Shareholder Benefit PlanPDFを開くPDF:116kb

Results of the Voluntary Retirement Program towards Strengthening JT’s Tobacco Business Operating ModelPDFを開くPDF:122kb

JT Announces Partial Amendments to Its Articles of IncorporationPDFを開くPDF:173kb
FY2021
December 21, 2021

JT to Apply to be Listed in the New “Prime Market” Segment of the Tokyo Stock ExchangePDFを開くPDF:159kb

November 24, 2021

JT Announces New Executive Appointments and Partial Amendment to Its Articles of IncorporationPDFを開くPDF:253kb

November 11, 2021

Leaf Tobacco Deliberative Council Releases Its Report in Response to 2022 Tobacco Cultivation ConsultationPDFを開くPDF:187kb

October 29, 2021

Consolidated Financial Results for the Nine Months Ended September 30, 2021 <under IFRS>PDFを開くPDF:371kb

2021 Third Quarter Results (CFO Presentation)PDFを開くPDF:306kb

Notice concerning revised dividends guidancePDFを開くPDF:117kb

Quarterly Securities ReportPDFを開くPDF:500kb

Written ConfirmationPDFを開くPDF:199kb

September 15, 2021

Notice of the Completion of Tender Offers by JT and JT’s Foreign Subsidiary and New Issuance of Foreign Currency Denominated Guaranteed Notes by JT’s Foreign SubsidiaryPDFを開くPDF:188kb

September 1, 2021

Notice of Tender Offers by JT and JT’s Foreign Subsidiary and New Issuance of Foreign Currency Denominated Guaranteed Notes by JT’s Foreign SubsidiaryPDFを開くPDF:228kb

August 30, 2021

Notice of Receipt of Dividend from JT’s Consolidated SubsidiaryPDFを開くPDF:120kb

Extraordinary ReportPDFを開くPDF:179kb

Amendment to Shelf Registration StatementPDFを開くPDF:154kb

August 27, 2021

JT Receives Approval to Amend Retail Prices of Heated Tobacco Products in Japan in Conjunction with the Revised Tax StructurePDFを開くPDF:160kb

August 23, 2021

JT Applies to Amend Retail Prices of Heated Tobacco Products in Japan in Conjunction with the Revised Tax StructurePDFを開くPDF:226kb

August 13, 2021

JT Receives Approval to Amend Retail Prices of Tobacco Products in Japan in Response to a Planned Excise Tax IncreasePDFを開くPDF:166kb

July 30, 2021

Consolidated Financial Results for the Six Months Ended June 30, 2021 <under IFRS>PDFを開くPDF:1054kb

2021 Second Quarter Results (CFO Presentation)PDFを開くPDF:442kb

JT Applies to Amend Retail Prices of Tobacco Products in Japan in Response to a Planned Excise Tax IncreasePDFを開くPDF:233kb

JT Announces New Executive AppointmentsPDFを開くPDF:124kb

Quarterly Securities ReportPDFを開くPDF:404kb

Written ConfirmationPDFを開くPDF:131kb

July 29, 2021

Leaf Tobacco Deliberative Council agrees to JT’s proposal to reduce the total tobacco cultivation area in Japan
PDFを開くPDF:124kb

July 15, 2021

JT Group launches Ploom X － The next generation heated tobacco device hits stores across Japan on August 17thPDFを開くPDF:535kb

May 26, 2021

Listing on the Japanese National Health Insurance Drug Price List and Launch of CORECTIM® Ointment 0.25% in JapanPDFを開くPDF:101kb

May 25, 2021

JT Terminates Exclusive License Agreement with EirGen Pharma for Calcifediol Extended-release Capsules (JTT-762)PDFを開くPDF:71kb

Notice Regarding Completion of Payment for Allocation of Treasury Stock towards Restricted Stock Remuneration PlanPDFを開くPDF:155kb

April 30, 2021

Consolidated Financial Results for the Three Months Ended March 31, 2021 <under IFRS>PDFを開くPDF:204kb

2021 First Quarter Results (CFO Presentation)PDFを開くPDF:204kb

Allocation of Treasury Stock towards Restricted Stock Remuneration PlanPDFを開くPDF:38kb

Securities Registration StatementPDFを開くPDF:63kb

Quarterly Securities ReportPDFを開くPDF:1,150kb

Written ConfirmationPDFを開くPDF:131kb

April 9, 2021

Notice of Receipt of Dividend from JT’s Consolidated SubsidiaryPDFを開くPDF:36kb

Extraordinary ReportPDFを開くPDF:83kb

Amendment to Shelf Registration StatementPDFを開くPDF:44kb

March 25, 2021

Extraordinary ReportPDFを開くPDF:89kb

Amendment to Shelf Registration StatementPDFを開くPDF:44kb

March 24, 2021

Annual Securities ReportPDFを開くPDF:2,269kb

Written ConfirmationPDFを開くPDF:130kb

Management's Report on Internal Control over Financial ReportingPDFを開くPDF:138kb

NOTICE OF RESOLUTIONS AT THE 36TH ORDINARY GENERAL MEETING OF SHAREHOLDERSPDFを開くPDF:116kb

March 23, 2021

JT Receives Approvals of CORECTIM® Ointment 0.25% and CORECTIM® Ointment 0.5% for the Treatment of Pediatric Atopic Dermatitis in JapanPDFを開くPDF:80kb

JT Receives Approval for Additional Indication for Iron Deficiency Anemia for Riona® and Promotion to Start in JapanPDFを開くPDF:74kb

February 26, 2021

Notice of ConvocationPDFを開くPDF:1.38mb

Materials Disclosed via The Internet Concerning Notice of ConvocationPDFを開くPDF:331kb

February 9, 2021

Consolidated Financial Results for the Fiscal Year Ended December 31, 2020 <under IFRS>PDFを開くPDF:301kb

Business Plan 2021 (Presentation)PDFを開くPDF:359kb

2020 Results & 2021 Forecast (Presentation)PDFを開くPDF:195kb

International Tobacco Business 2020 Results & 2021 Outlook（Presentation)PDFを開くPDF:459kb

JT Group Announces New Operating Model Company Aims to Strengthen its Tobacco BusinessPDFを開くPDF:107kb

January 13, 2021

JT expands sales area for “Ploom TECH+ with”, a Tobacco-Infused Vapor DevicePDFを開くPDF:232kb
FY2020
November 24, 2020

JT Announces New Executive AppointmentsPDFを開くPDF:87kb

November 20, 2020

Change Report No. 8 (Tokyo Automatic Machinery Works, Ltd.)PDFを開くPDF:19kb

Change Report No. 3 (TORII PHARMACEUTICAL CO., LTD.)PDFを開くPDF:91kb

Change Report No. 7 (JAPAN TOBACCO INC.)PDFを開くPDF:19kb

November 18, 2020

Listing on the Japanese National Health Insurance Drug Price List and Launch of ENAROY® Tablets 2 mg･4 mg for the Treatment of Anemia Associated with Chronic Kidney Disease in JapanPDFを開くPDF:68kb

October 30, 2020

Consolidated Financial Results for the Nine Months Ended September 30, 2020 <under IFRS>PDFを開くPDF:114kb

2020 Third Quarter Results (CFO Presentation)PDFを開くPDF:187kb

Quarterly Securities ReportPDFを開くPDF:234kb

Written ConfirmationPDFを開くPDF:33kb

October 7, 2020

JT launches “Ploom TECH+ with”, a Tobacco-Infused Vapor DevicePDFを開くPDF:246kb

October 1, 2020

Notice of Issuance of Foreign Currency Denominated Subordinated Bonds by JT Foreign SubsidiaryPDFを開くPDF:66kb

September 25, 2020

JT Receives Manufacturing and Marketing Approval of ENAROY® Tablets 2 mg・4 mg for the Treatment of Anemia Associated with Chronic Kidney Disease in JapanPDFを開くPDF:311kb

August 28, 2020

Notice of Receipt of Dividend from JT’s Consolidated SubsidiaryPDFを開くPDF:32kb

Extraordinary ReportPDFを開くPDF:34kb

Amendment to Shelf Registration StatementPDFを開くPDF:38kb

August 19, 2020

JT Receives Approval to Amend Retail Prices of Tobacco Products in Japan in Response to a Planned Excise Tax IncreasePDFを開くPDF:82kb

August 6, 2020

Shelf Registration StatementPDFを開くPDF:41kb

Overview of Business and Trends in Principal Management BenchmarksPDFを開くPDF:104kb

Statement verifying eligibility for use of “Reference Method”PDFを開くPDF:30kb

July 31, 2020

Consolidated Financial Results for the Six Months Ended June 30, 2020 <under IFRS>PDFを開くPDF:394kb

2020 Second Quarter Results (CFO Presentation)PDFを開くPDF:229kb

JT Applies to Amend Retail Prices of Tobacco Products in Japan in Response to a Planned Excise Tax IncreasePDFを開くPDF:85kb

JT to relocate its head office on October 5, 2020PDFを開くPDF:208kb

Quarterly Securities ReportPDFを開くPDF:603kb

Written ConfirmationPDFを開くPDF:33kb

June 10, 2020

Notice of Change in Specified SubsidiaryPDFを開くPDF:92kb

June 1, 2020

JT launches Ploom S 2.0, an upgraded Heated Tobacco device and two tobacco stick products NationwidePDFを開くPDF:449kb

May 29, 2020

JT Files New Drug Application of JTE-052 Ointment, JAK inhibitor, for the Treatment of Pediatric Atopic Dermatitis in JapanPDFを開くPDF:76kb

May 26, 2020

Notice Regarding Completion of Payment for Allocation of Treasury Stock towards Restricted Stock Remuneration PlanPDFを開くPDF:129kb

May 22, 2020

Business Report Vol.64PDFを開くPDF:140kb

May 15, 2020

JT Files for Additional Indication for Riona®, Ferric Citrate Hydrate, for Iron Deficiency Anemia in JapanPDFを開くPDF:83kb

April 30, 2020

Consolidated Financial Results for the Three Months Ended March 31, 2020 <under IFRS>PDFを開くPDF:258kb

2020 First Quarter Results (CFO Presentation)PDFを開くPDF:245kb

Allocation of Treasury Stock towards Restricted Stock Remuneration PlanPDFを開くPDF:117kb

Securities Registration StatementPDFを開くPDF:134kb

Quarterly Securities ReportPDFを開くPDF:494kb

Written ConfirmationPDFを開くPDF:150kb

April 24, 2020

Amendment Report of Securities ReportPDFを開くPDF:170kb

Written ConfirmationPDFを開くPDF:117kb

Amendment to Shelf Registration StatementPDFを開くPDF:116kb

April 22, 2020

Listing on the Japanese National Health Insurance Drug Price List and Launch of CORECTIM® Ointment 0.5% for the Treatment of Atopic Dermatitis in JapanPDFを開くPDF:94kb

March 27, 2020

Notice of Receipt of Dividend from JT’s Consolidated SubsidiaryPDFを開くPDF:97kb

Extraordinary ReportPDFを開くPDF:135kb

Amendment to Shelf Registration StatementPDFを開くPDF:116kb

March 23, 2020

Extraordinary ReportPDFを開くPDF:151kb

Amendment to Shelf Registration StatementPDFを開くPDF:137kb

March 19, 2020

Annual Securities ReportPDFを開くPDF:2,257kb

Written ConfirmationPDFを開くPDF:130kb

Management's Report on Internal Control over Financial ReportingPDFを開くPDF:138kb

ARTCLES OF INCORPORATIONPDFを開くPDF:141kb

NOTICE OF RESOLUTIONS AT THE 35TH ORDINARY GENERAL MEETING OF SHAREHOLDERSPDFを開くPDF:19kb

March 10, 2020

Notice of Correction to Notice of ConvocationPDFを開くPDF:203kb

February 26, 2020

Notice of ConvocationPDFを開くPDF:1.62mb

Materials Disclosed via The Internet Concerning Notice of ConvocationPDFを開くPDF:514kb

February 6, 2020

Consolidated Financial Results for the Fiscal Year Ended December 31, 2019 <under IFRS>PDFを開くPDF:408kb

Business Plan 2020 (Presentation)PDFを開くPDF:196kb

2019 Results & 2020 Forecast (Presentation)PDFを開くPDF:199kb

International Tobacco Business 2019 Results & 2020 Outlook（Presentation)PDFを開くPDF:453kb

Introduction of Restricted Stock Remuneration Plan and Performance Share Unit PlanPDFを開くPDF:370kb

January 28, 2020

Notice of Financing through Subordinated LoanPDFを開くPDF:131kb

January 23, 2020

JT Receives Manufacturing and Marketing Approval of CORECTIM® Ointment 0.5% for the Treatment of Atopic Dermatitis in JapanPDFを開くPDF:309kb

January 22, 2020

Japanese Domestic Cigarette Sales Results for December 2019 (Preliminary Report)PDFを開くPDF:396kb

January 20, 2020

Notice Concerning Amendments to Earnings Forecasts of a SubsidiaryPDFを開くPDF:264kb

January 15, 2020

JT Signs Exclusive License Agreements with Dermavant and Torii for Development and Commercialization of Tapinarof in JapanPDFを開くPDF:293kb

January 6, 2020

Extraordinary ReportPDFを開くPDF:100kb

Amendment to Shelf Registration StatementPDFを開くPDF:116kb

Archive